IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.

Research IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. (300896.SZ) on Bullrun: market cap CNY 29.00B, P/E 26.4, dividend yield 1.9%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is CNY 29.00B; P/E is 26.4; dividend yield is 1.9%.

Peer valuation comparison

Latest P/E is 26.4x versus a Healthcare sector median of 21.69x (21.7% above).

Latest dividend yield is 1.88% versus a Healthcare sector median of 2.41% (22.0% below).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18CNY 29.00B26.41.9%1.8

Dividend history

Latest trailing dividend snapshot: annual dividend/share 1.8 CNY, yield 1.9%.

About IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.

Imeik Technology Development Co.,Ltd. engages in the research and development, and transformation of biomedical materials and biopharmaceutical products in China. The company offers aesthetic medicine products, such as cross-linked sodium hyaluronate gel with PLLA-b-PEG microsphere; poly facial implant thread; medical sodium hyaluronate-hydroxypropyl methylcellulose gel; sodium hyaluronate composite solution for injection; modified sodium hyaluronate gel for injection;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.'s market cap?

IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.'s market capitalization is CNY 29.00B.

What is IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.'s P/E ratio?

IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.'s price-to-earnings (P/E) ratio is 26.4.

Does IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. pay a dividend?

IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. has a dividend yield of 1.9%.

What does IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. do?

Imeik Technology Development Co.,Ltd. engages in the research and development, and transformation of biomedical materials and biopharmaceutical products in China. The company offers aesthetic medicine products, such as cross-linked sodium hyaluronate gel with PLLA-b-PEG microsphere; poly facial implant thread; medical sodium hyaluronate-hydroxypropyl methylcellulose gel; sodium hyaluronate composite solution for injection; modified sodium hyaluronate gel for injection; medical PVA gel ball-sodium hyaluronate-hydroxypropyl methylcellulose gel; and skin care products.